For Xenotransplantation that Does Not Require Systemic Immunosuppression Intravascular Immunofiltration Device

Abstract

This invention allows for systemic complications during the transplantation of genetically modified pig kidneys into humans. arterial vessels aiming to eliminate the need for immunosuppression It involves an intravascular immune filtration device implanted inside. Bioselective. This device, which has microfiltration membranes, can process T cells, B cells, and macrophages. and prevent immunodeficiency by retaining antibodies before they reach the graft tissue. targets. This approach reduces the risk of rejection while improving the overall immune system of the recipient. It retains its function.